- Home
- GNFT vs RZLT Comparison
GNFT vs RZLT Comparison
Compare GNFT & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- RZLT
- Stock Information
- Founded
- GNFT 1999
- RZLT 2010
- Country
- GNFT France
- RZLT United States
- Employees
- GNFT N/A
- RZLT N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- GNFT Health Care
- RZLT Health Care
- Exchange
- GNFT Nasdaq
- RZLT Nasdaq
- Market Cap
- GNFT 296.4M
- RZLT 292.0M
- IPO Year
- GNFT 2019
- RZLT N/A
- Fundamental
- Price
- GNFT $3.79
- RZLT $4.34
- Analyst Decision
- GNFT Strong Buy
- RZLT Strong Buy
- Analyst Count
- GNFT 1
- RZLT 8
- Target Price
- GNFT $13.00
- RZLT $11.63
- AVG Volume (30 Days)
- GNFT 6.6K
- RZLT 386.7K
- Earning Date
- GNFT 09-19-2024
- RZLT 02-11-2025
- Dividend Yield
- GNFT N/A
- RZLT N/A
- EPS Growth
- GNFT N/A
- RZLT N/A
- EPS
- GNFT 0.47
- RZLT N/A
- Revenue
- GNFT $86,225,222.00
- RZLT N/A
- Revenue This Year
- GNFT $155.44
- RZLT N/A
- Revenue Next Year
- GNFT N/A
- RZLT N/A
- P/E Ratio
- GNFT $7.85
- RZLT N/A
- Revenue Growth
- GNFT 175.45
- RZLT N/A
- 52 Week Low
- GNFT $3.31
- RZLT $0.86
- 52 Week High
- GNFT $6.42
- RZLT $6.19
- Technical
- Relative Strength Index (RSI)
- GNFT 26.93
- RZLT 34.33
- Support Level
- GNFT $3.63
- RZLT $4.42
- Resistance Level
- GNFT $3.85
- RZLT $5.29
- Average True Range (ATR)
- GNFT 0.12
- RZLT 0.35
- MACD
- GNFT 0.01
- RZLT -0.07
- Stochastic Oscillator
- GNFT 11.88
- RZLT 13.43
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.